ROYSTON IVOR (CEO & President) sold 2.1% of their position (13.38K shares) of VIRACTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $53.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/29/2022ACC: 0001209191-22-047947
DirectorOfficer· CEO & President
Since Feb 2021
-13.38K
Net shares
Net seller
$53.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25.22K acquired · 38.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25.22K
Price / share
—
Trade value
—
% of position
4.2%
8/25/2022
600.93K→626.15K
Common Stock
Direct
Shares
−13.38K
Price / share
$4.01
Trade value
$53.66K
% of position
2.1%
8/26/2022
626.15K→612.77K
Total
Net shares
+11.84K
Net value
-$53.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2022 | M · Option Exercise | +25.22K | — | — | 4.2% | 600.93K | 626.15K |
| Common Stock Direct | 8/26/2022 | S · Sale | −13.38K | $4.01 | $53.66K | 2.1% | 626.15K | 612.77K |
| Total | +11.84K | -$53.66K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
25.22K shares
Shares
−25.22K
Strike price
Held after
277.41K
Exercisable
—
8/25/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock25.22K shares | 8/25/2022 | M · Option Exercise | −25.22K | — | 277.41K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned18.60K
Total
18.60K indirect18.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18.60K | Indirect |
| Total | 18.60K | 18.60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported